HCW Biologics Inc. (HCWB)

AI Score

Unlock

7.92

-0.01 (-0.13%)

At close: Apr 24, 2025, 3:59 PM

7.94

0.25%

After-hours: Apr 24, 2025, 04:00 PM EDT

HCW Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	4.67M	998.22K	1.16M	4.08M	3.6M	11.22M	7.45M	18.39M	22.33M	26.22M	15.42M	18.12M	11.73M	15.13M	5.05M	6.86M	8.46M	-7.36M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	9.96M	9.85M	9.74M	n/a	16.99M	16.97M	24.98M	24.99M	n/a	n/a	n/a	14.71M
Long-Term Investments	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	11.27M	11.3M	11.35M	11.52M	11.58M	1.6M	1.6M	1.6M	n/a
Other Long-Term Assets	28.48K	28.48K	28.48K	28.48K	56.54K	5.39M	5.46M	253.14K	333.88K	419.03K	563.51K	686.41K	393.32K	n/a	n/a	n/a	34.24K	-7.36M
Receivables	582.2K	651.84K	654.97K	1.15M	1.54M	710.08K	707.21K	252.73K	417.69K	355.56K	346.93K	553.01K	133K	70K	50K	1.3M	2.5M	n/a
Inventory	n/a	n/a	n/a	1.00	n/a	1.74M	1.36M	n/a	1.39M	1.00	1.4M	2.02M	2.2M	1.99M	4.05M	783.32K	538.31K	n/a
Other Current Assets	113.53K	88.13K	164.61K	187.27K	230.92K	174.88K	327.06K	316.96K	196.01K	205.92K	470.02K	245.62K	1.44M	1.38M	4.08M	859.87K	654.53K	n/a
Total Current Assets	5.7M	2.09M	2.39M	6.21M	6.4M	13.85M	19.8M	29.94M	34.07M	28.71M	34.63M	37.91M	40.48M	43.56M	10.05M	9.8M	12.15M	7.36M
Property-Plant & Equipment	22.91M	22.83M	22.81M	22.59M	20.45M	14.78M	12.62M	11.74M	10.8M	10.96M	913.73K	1.01M	1.12M	1.27M	1.39M	1.53M	1.62M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	24.54M	24.46M	24.43M	24.22M	22.11M	21.77M	19.68M	13.59M	12.74M	22.65M	12.78M	13.05M	13.03M	12.85M	2.99M	3.13M	3.25M	-7.36M
Total Assets	30.24M	26.56M	26.82M	30.43M	28.51M	35.62M	39.48M	43.53M	46.81M	51.35M	47.41M	50.96M	53.51M	56.41M	13.03M	12.93M	15.4M	n/a
Account Payables	22.33M	22.67M	16.88M	10.49M	6.17M	3.15M	2.12M	1.16M	1.23M	1.41M	296.21K	743.12K	223.66K	637.19K	996.88K	323.5K	155.34K	n/a
Deferred Revenue	n/a	n/a	n/a	-122.15K	n/a	-117.68K	-97.1K	n/a	n/a	n/a	n/a	n/a	1.8M	n/a	n/a	n/a	-567.31K	n/a
Short-Term Debt	6.31M	6.34M	124K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	204.68K	n/a	-28.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	29.63M	30.06M	23.22M	13.41M	8.75M	5.42M	4.54M	4.52M	2.96M	2.29M	1.14M	1.42M	2.32M	2.39M	4.17M	1.35M	1M	n/a
Long-Term Debt	7.38M	6.46M	9.9M	8.27M	6.3M	6.33M	6.36M	6.39M	6.41M	6.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.48K	14.28K	56.68K	98.45K	139.6K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	7.38M	6.46M	9.9M	8.27M	6.3M	6.33M	6.36M	6.39M	6.42M	6.5M	98.45K	139.6K	223.66K	n/a	n/a	n/a	n/a	n/a
Total Liabilities	37.01M	36.53M	33.12M	21.69M	15.05M	11.75M	10.9M	10.92M	9.38M	8.8M	1.24M	1.56M	2.32M	2.39M	4.17M	1.35M	1M	n/a
Total Debt	13.69M	12.8M	10.02M	8.27M	6.45M	6.33M	6.36M	6.39M	6.41M	6.45M	98.45K	139.6K	n/a	n/a	n/a	n/a	567.31K	n/a
Common Stock	4.45K	3.78K	3.78K	3.78K	3.6K	3.59K	3.59K	3.59K	3.59K	3.58K	3.58K	3.58K	3.58K	3.57K	496.00	488.00	480.00	n/a
Retained Earnings	-100.56M	-97.18M	-93.28M	-78M	-70.53M	-59.85M	-54.91M	-50.61M	-45.54M	-40.12M	-36.21M	-32.69M	-30.64M	-27.46M	-23.24M	-20.03M	-16.72M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	0.00	n/a	0.00	0.00	-56.41M	-23.24M	-1.14K	n/a	-9.68M
Shareholders Equity	-6.77M	-9.97M	-6.3M	8.74M	13.46M	23.87M	28.59M	32.62M	37.43M	42.56M	46.17M	49.4M	51.19M	54.01M	8.86M	11.58M	14.4M	9M
Total Investments	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	11.56M	11.45M	11.34M	11.27M	28.3M	28.32M	36.51M	36.57M	1.6M	1.6M	1.6M	14.71M